Randy Kardon
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Randy Kardon sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Randy Kardon: 4 sponsored US clinical trials, 3 recruiting.
Randy Kardon sponsors 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting. The most-studied condition in this pipeline is Acute Zonal Occult Outer Retinopathy, with 1 trials.
Upper-quartile sponsor footprint
Randy Kardon sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Objectively Diagnose and Monitor Treatment of Light Sensitivity
NCT03694626
New Non-invasive Modalities for Assessing Retinal Structure and Function
NCT03475173
Smartphone Flicker Fusion Test for Patients With Optic Disorders.
NCT03475147
LSFG-SKIN, Laser Speckle Flowgraphy
NCT03660618
What is open in the Randy Kardon pipeline
3 recruiting of 4 indexed (75% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Acute Zonal Occult Outer Retinopathy (1 trial), 8 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Randy Kardon: open-pipeline peers nationwide
Peers matched on 4 registered trials and 75% open enrollment, not the therapeutic-area sidebar.
Randy Kardon sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 75% open enrollment (± trial volume)
- Acepodia Biotech · 75% recruiting · 4 trials
- American Laboratory Products Company · 75% recruiting · 4 trials
- Amryt Pharma · 75% recruiting · 4 trials
- Amydis · 75% recruiting · 4 trials
Related
What to do with this Randy Kardon page
4 registered trials is a research-attention snapshot, not an endorsement of Randy Kardon or any single study.
- 3 of Randy Kardon's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Acute Zonal Occult Outer Retinopathy is the condition Randy Kardon studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Acute Zonal Occult Outer Retinopathy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Randy Kardon pipeline card: 4 registered trials from official public datasets.Report a data error.